Explore
Validate
LearnOAAB05809
antibody from Aviva Systems Biology
Targeting: ERGIC3
C20orf47, CGI-54, Erv46, NY-BR-84, PRO0989, SDBCAG84
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- OAAB05809 - Provider product page
- Provider
- Aviva Systems Biology
- Product name
- ERGIC3 antibody - N-terminal region
- Antibody type
- Polyclonal
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 400ul
- Storage
- Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Western blot analysis of ERGIC3 (arrow) using rabbit polyclonal ERGIC3 Antibody (N-term) either nontransfected (Lane 1) or lysates transiently transfected transfected (Lane 2) with the ERGIC3 gene.
- Sample type
- lysatestransiently transfected with the ERGIC3 gene.
- Primary Ab dilution
- 1.0 µg/mL
- Protocol
- Protocol
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Western blot analysis of ERGIC3 Antibody (N-term) in HepG2 cell lysates (35ug/lane). ERGIC3 (arrow) was detected using the purified Pab.
- Sample type
- HepG2 cell line lysates
- Primary Ab dilution
- 1.0 µg/mL
- Protocol
- Protocol
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Formalin-fixed and paraffin-embedded human hepatocarcinoma reacted with ERGIC3 Antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.
- Sample type
- human hepatocarcinoma
- Primary Ab dilution
- 1.0 µg/mL
- Protocol
- Protocol
